Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments
Evidence suggests that the peak skeletal muscle mitochondrial ATP synthesis rate (V max)
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments
C Hart, G Layec, J Trinity, Y Le Fur, J Gifford… - AJP-Heart and …, 2018 - hal.science
Evidence suggests that the peak skeletal muscle mitochondrial ATP synthesis rate (V max)
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments.
CR Hart, G Layec, JD Trinity, Y Le Fur… - American Journal of …, 2018 - europepmc.org
Evidence suggests that the peak skeletal muscle mitochondrial ATP synthesis rate (V max)
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments
CR Hart, G Layec, JD Trinity, Y Le Fur… - American Journal of …, 2018 - cir.nii.ac.jp
抄録< jats: p> Evidence suggests that the peak skeletal muscle mitochondrial ATP synthesis
rate (V< jats: sub> max</jats: sub>) in patients with peripheral artery disease (PAD) may be …
rate (V< jats: sub> max</jats: sub>) in patients with peripheral artery disease (PAD) may be …
[PDF][PDF] Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments
CR Hart, G Layec, JD Trinity, Y Le Fur… - Am J Physiol Heart …, 2018 - researchgate.net
Peripheral artery disease (PAD) is characterized by insufficient tissue O2 supply secondary
to reduced blood flow both at rest and during even submaximal exercise (49, 64, 67). This …
to reduced blood flow both at rest and during even submaximal exercise (49, 64, 67). This …
Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments
CR Hart, G Layec, JD Trinity… - American journal …, 2018 - pubmed.ncbi.nlm.nih.gov
Evidence suggests that the peak skeletal muscle mitochondrial ATP synthesis rate (V max)
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments.
CR Hart, G Layec, JD Trinity, Y Le Fur… - American Journal of …, 2018 - europepmc.org
Evidence suggests that the peak skeletal muscle mitochondrial ATP synthesis rate (V max)
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …
in patients with peripheral artery disease (PAD) may be attenuated due to disease-related …